Core Viewpoint - Rosen Law Firm is urging investors of Neumora Therapeutics, Inc. to secure legal counsel before the April 7, 2025 deadline for a securities class action related to the company's IPO in September 2023 [1][2]. Group 1: Legal Action Details - Investors who purchased Neumora common stock may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must act by April 7, 2025 [3]. - The Rosen Law Firm emphasizes the importance of selecting qualified counsel with a proven track record in securities class actions [4]. Group 2: Case Allegations - The lawsuit alleges that the Offering Documents contained false or misleading statements, including the necessity for Neumora to amend trial criteria to justify its Phase Three Program [5]. - It is claimed that the Phase Two Trials lacked adequate data regarding patient population size and gender ratio, which could affect the predictability of the KOASTAL-1 study results [5].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased common stock of Integral Ad Science Holding Corp. (NASDAQ: IAS) during the Class Period from March 2, 2023, to February 27, 2024, about the lead plaintiff deadline of March 31, 2025, for a class action lawsuit [1] Group 1: Class Action Details - Investors who bought IAS common stock during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] - A class action lawsuit has already been filed, and interested parties can join by contacting Rosen Law Firm [2][5] - The lead plaintiff must file a motion with the Court by March 31, 2025, to represent other class members in the litigation [2] Group 2: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company at the time [3] - The firm was ranked No. 1 by ISS Securities Class Action Services for the number of settlements in 2017 and has consistently ranked in the top 4 since 2013, recovering hundreds of millions for investors [3] - In 2019, the firm secured over $438 million for investors, and its founding partner was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020 [3] Group 3: Case Allegations - The lawsuit alleges that IAS failed to disclose significant competitive pricing pressures, leading to price cuts due to weakening demand and slowing revenue growth [4] - It is claimed that IAS's pricing function was no longer favorable, and the company could not sustain its pricing or drive price increases [4] - The lawsuit asserts that IAS's public statements were materially false and misleading, resulting in investor damages when the true details were revealed [4]

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Rocket Lab USA, Inc. (NASDAQ: RKLB) between November 12, 2024 and February 25, 2025, both dates inclusive (the "Class Period"), of the important April 28, 2025 lead plaintiff deadline. SO WHAT: If you purchased Rocket Lab securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the Rocket L ...

NEW YORK, March 29, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Grocery Outlet Holding Corp. (NASDAQ: GO) with an expanded class period between August 9, 2023 and October 29, 2024, both dates inclusive (the "Class Period"), of the important March 31, 2025 lead plaintiff deadline. SO WHAT: If you purchased Grocery Outlet securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or c ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased common stock of Monolithic Power Systems, Inc. during the specified class period of the upcoming lead plaintiff deadline on April 7, 2025 [1] Group 1: Class Action Details - Investors who bought Monolithic Power Systems common stock between February 8, 2024, and November 8, 2024, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2] - A class action lawsuit has already been filed, and interested parties can join by contacting the law firm [3][6] - The lead plaintiff must file a motion with the court by April 7, 2025, to represent other class members in the litigation [3] Group 2: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company at the time [4] - The firm was ranked No. 1 by ISS Securities Class Action Services for the number of securities class action settlements in 2017 and has consistently ranked in the top 4 since 2013, recovering hundreds of millions of dollars for investors [4] - In 2019, the firm secured over $438 million for investors, and its founding partner was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020 [4] Group 3: Case Allegations - The lawsuit alleges that Monolithic Power Systems made materially false and misleading statements regarding its voltage regulator modules and power management integrated circuits, which suffered from significant performance and air quality issues [5] - These defects negatively impacted the performance of products offered by Nvidia that utilized Monolithic Power Systems' components [5] - The relationship between Monolithic Power Systems and Nvidia was reportedly damaged due to these performance and quality control problems, exposing the company to undisclosed risks of significant business, financial, and reputational harm [5]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Target Corporation common stock between August 26, 2022, and November 19, 2024, of the April 1, 2025, lead plaintiff deadline for a class action lawsuit related to misleading statements made by Target regarding its ESG and DEI initiatives [1][4]. Group 1: Class Action Details - Investors who bought Target stock during the specified period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties can join by submitting a form or contacting the law firm [2][6]. - The lead plaintiff must file a motion with the court by April 1, 2025, to represent other class members in the litigation [2]. Group 2: Allegations Against Target - The lawsuit claims that Target misled investors with false statements about its ESG and DEI mandates, which led to significant customer boycotts following the 2023 LGBT-Pride Campaign [4]. - The negative impact of the Campaign resulted in a decline in Target's stock price and sales falling for the first time in six years [5]. - It is alleged that Target's CEO and Board did not disclose known risks associated with the 2023 and 2024 Campaigns, leading to investors purchasing stock at artificially inflated prices [5].

Core Viewpoint - Rosen Law Firm is reminding purchasers of Class A common stock of The Trade Desk, Inc. about the upcoming lead plaintiff deadline for a class action lawsuit related to misleading statements made by the company during the specified Class Period [1][5]. Group 1: Class Action Details - Investors who purchased Trade Desk Class A common stock between May 9, 2024, and February 12, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by April 21, 2025 [3][5]. - The lawsuit alleges that Trade Desk made false and misleading statements regarding its business operations and the rollout of its AI forecasting tool, Kokai, which negatively impacted revenue growth [5]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements in recovering hundreds of millions for investors [4]. - The firm has been recognized for its leadership in securities class action settlements, achieving the largest settlement against a Chinese company at the time and ranking No. 1 for the number of settlements in 2017 [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Walgreens Boots Alliance, Inc. common stock between April 2, 2020, and January 16, 2025, of the March 31, 2025, lead plaintiff deadline for a class action lawsuit [1]. Group 1: Class Action Details - Investors who purchased Walgreens common stock during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by submitting a form or contacting the law firm [3][6]. - To serve as lead plaintiff, individuals must file a motion with the Court by March 31, 2025 [3]. Group 2: Law Firm Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions [4]. - The firm has achieved significant settlements, including the largest securities class action settlement against a Chinese company at the time and has been ranked highly for its performance in securities class action settlements [4]. - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering funds for clients [4]. Group 3: Case Allegations - The lawsuit alleges that Walgreens failed to disclose widespread violations of federal law regarding prescription medication dispensation and reimbursement during the Class Period [5]. - It is claimed that Walgreens' conduct posed a heightened risk of regulatory scrutiny, civil liability, and reputational harm, leading to materially false and misleading public statements [5]. - The lawsuit asserts that when the true details were revealed, investors suffered damages due to the unsustainable nature of Walgreens' revenues from unlawful conduct [5].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Merck & Co., Inc. securities between February 3, 2022, and February 3, 2025, about the April 14, 2025, deadline to become a lead plaintiff in a class action lawsuit [1]. Group 1: Class Action Details - Investors who purchased Merck securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by April 14, 2025 [2]. - The Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions [3]. Group 2: Case Background - The lawsuit alleges that throughout the Class Period, Merck provided misleading information regarding expected revenue of $11 billion from Gardasil sales by 2030, while concealing adverse facts about demand visibility in China [4]. - Defendants reportedly made overly optimistic statements about Gardasil's growth potential in China, despite lacking insight into actual demand among targeted populations, leading to inflated inventory levels [4].

NEW YORK, March 26, 2025 /PRNewswire/ --Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Newmont Corporation (NYSE: NEM) between February 22, 2024 and October 23, 2024, inclusive (the "Class Period"), of the important April 1, 2025 lead plaintiff deadline.So what: If you purchased Newmont securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.What to do next: To ...